<!DOCTYPE html>
<html lang="en"><head>
  <meta charset="utf-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <title>About</title>
  <meta name="description" content="by Dr Mark Wardle, Consultant Neurologist and Chief Clinical Information Officer (CCIO)">

  <link rel="stylesheet" href="/assets/main.css">
  <link rel="canonical" href="https://www.wardle.org/about/">
  <link rel="alternate" type="application/rss+xml" title="Health informatics and information technology" href="/feed.xml">
  
  <script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-97389603-1', 'auto');
  ga('send', 'pageview');

</script>
</head>
<body><header class="site-header" role="banner">

  <div class="wrapper">
    
    
    <a class="site-title" href="/">Health informatics and information technology</a>
  
  
    
      <nav class="site-nav">
        <input type="checkbox" id="nav-trigger" class="nav-trigger" />
        <label for="nav-trigger">
          <span class="menu-icon">
            <svg viewBox="0 0 18 15" width="18px" height="15px">
              <path fill="#424242" d="M18,1.484c0,0.82-0.665,1.484-1.484,1.484H1.484C0.665,2.969,0,2.304,0,1.484l0,0C0,0.665,0.665,0,1.484,0 h15.031C17.335,0,18,0.665,18,1.484L18,1.484z"/>
              <path fill="#424242" d="M18,7.516C18,8.335,17.335,9,16.516,9H1.484C0.665,9,0,8.335,0,7.516l0,0c0-0.82,0.665-1.484,1.484-1.484 h15.031C17.335,6.031,18,6.696,18,7.516L18,7.516z"/>
              <path fill="#424242" d="M18,13.516C18,14.335,17.335,15,16.516,15H1.484C0.665,15,0,14.335,0,13.516l0,0 c0-0.82,0.665-1.484,1.484-1.484h15.031C17.335,12.031,18,12.696,18,13.516L18,13.516z"/>
            </svg>
          </span>
        </label>

        <div class="trigger">
           <a class="page-link" href="/">All posts</a>
          
            
            
            <a class="page-link" href="/projects/">Projects</a>
            
          
            
            
            <a class="page-link" href="/about/">About</a>
            
          
            
            
          
            
            
          
            
            
          
        </div>
      </nav>
    
  </div>
</header>
<main class="page-content" aria-label="Content">
      <div class="wrapper">
        <article class="post">

  <header class="post-header">
    <h1 class="post-title">About</h1>
  </header>

  <div class="post-content">
    <p>Dr. Mark Wardle MB BCh MD FRCP</p>

<h1 id="employment--roles">Employment / roles</h1>

<ul>
  <li>Consultant Neurologist - <a href="http://www.cardiffandvaleuhb.wales.nhs.uk">Cardiff and Vale University Health Board</a>, 2011-</li>
  <li>Chair, NHS Wales Technical Standards Board, 2018-</li>
  <li>Clinical databases lead and Principal Investigator, <a href="http://brain.wales">BRAIN unit</a>, 2013-</li>
  <li>Honorary Clinical Lecturer - <a href="http://www.cf.ac.uk">Cardiff University</a>, 2011-</li>
  <li>Clinical informatician, <a href="http://www.cardiffandvaleuhb.wales.nhs.uk">Cardiff and Vale University Health Board</a>, 2016-</li>
  <li>Founder, <a href="http://eldrix.com">Eldrix Ltd</a>, Electronic patient record software 2012-</li>
</ul>

<h1 id="past-employment">Past employment</h1>

<ul>
  <li>Deputy Sub-Dean for Assessments, School of Medicine, <a href="http://www.cf.ac.uk">Cardiff University</a>, 2012-2016</li>
  <li>Clinical design, <a href="http://www.wales.nhs.uk/nwis/">NHS Wales informatics service</a>, 2016-2018</li>
</ul>

<h1 id="qualifications-and-prizes">Qualifications and prizes</h1>

<ul>
  <li>NHS Wales Awards Winner 2019 - South East Wales MND network</li>
  <li>Founding Fellow, Faculty of Clinical Informatics, 2018-</li>
  <li>Fellowship of the Royal College of Physicians, 2015-</li>
  <li>Doctorate of Medicine, Cardiff University, 2009 - <a href="/images/wardle-2009-thesis.pdf">Cerebellar ataxia: A clinical and genetic study in South Wales</a></li>
  <li>Sir Charles Symonds Prize, Association of British Neurologists, Best Platform Presentation, 2007</li>
  <li>Membership of the Royal College of Physicians, 2004</li>
  <li>MB BCh, University of Wales College of Medicine, 1999</li>
  <li>Elizabeth Pipe Prize in Paediatrics, 1999</li>
</ul>

<h1 id="grants">Grants</h1>

<ul>
  <li>Gray L et al. NIHSCR Wales BRAIN unit, £1,499,910 July 2015-</li>
  <li>Bisson J et al. Biobanking Research support, NIHSCR AHSC, £130,322, Apr 2012-Mar 2015</li>
</ul>

<h1 id="roles-and-responsibilities">Roles and responsibilities</h1>
<h4 id="clinical">Clinical</h4>

<ul>
  <li>General neurology, University Hospital Wales and Prince Charles Hospital	2011-
    <ul>
      <li>Two clinics per week</li>
      <li>Two ward referral sessions per week</li>
      <li>On-call for neurology and stroke thrombolysis</li>
    </ul>
  </li>
  <li>Specialist ataxia and movement disorders clinic, Cardiff and Vale		2011-
    <ul>
      <li>One clinic per week</li>
    </ul>
  </li>
  <li>Specialist motor neurone disease clinic: Prince Charles Hospital		2012-
    <ul>
      <li>One clinic per month</li>
    </ul>
  </li>
  <li>Clinical lead for IT for Welsh Clinical Portal project, Cardiff and Vale 		2011-2015</li>
  <li>Educational and clinical supervisor, Wales Deanery				2011-</li>
  <li>Medical expert for Court of Protection, December 2015</li>
</ul>

<h4 id="non-clinical">Non-clinical</h4>

<ul>
  <li>Shortlisting and judge, COVID-19 digital solutions fund, 2020</li>
  <li>Member, “Digital transformation panel”, Welsh Assembly Government, 2018 (<a href="/images/systemreboot.pdf">“System reboot” report</a>)</li>
  <li>Designer and clinical lead for COM2 project, Cardiff and Vale University Health Board providing outpatient management and SNOMED CT functionality</li>
  <li>Shortlisting and judge, <a href="https://www.intel.co.uk/content/www/uk/en/analytics/artificial-intelligence/pioneering-ai-healthcare-solutions-article.html">Intel AI grant</a>, 2019</li>
  <li>NHS Wales Architecture Review Advisory Group, 2019</li>
  <li>Interviewed by <a href="https://www.wired.co.uk/article/ai-healthcare-gp-deepmind-privacy-problems">Wired magazine on privacy and artificial intelligence in healthcare</a></li>
  <li>Member, Clinical Content subcommittee, <a href="https://apperta.org">Apperta Foundation</a>, 2017-2018</li>
  <li>Member, “Once for Wales” Task and Finish Group, Welsh Assembly Government, 2017-2018</li>
  <li>Information standards, Task and finish group, 2016-2017.</li>
  <li>Member, Welsh Clinical Informatics Council, NHS Wales Informatics Service, 2015-</li>
  <li>Co-director, South Wales Motor Neurone Disease Network, 2015-</li>
  <li><a href="https://www.mndassociation.org/research/mnd-register-for-england-wales-and-northern-ireland/">National UK MND register</a> steering group, 2015-</li>
  <li>Clinical databases lead, NISCHR BRAIN unit, 2015-</li>
  <li>Association of British Neurologists Neurogenetics Advisory Group, 2015-2018</li>
  <li>Wales Neuromuscular network steering group, 2013-</li>
  <li>Medical Schools Council Assessment Alliance (MSA-AA) reference group	2012-2016</li>
  <li>Ataxia UK, medical advisory panel, 2012-</li>
  <li>Clinical advisor, Welsh Neurosciences Research Tissue Bank (WNRTB), 2012-</li>
</ul>

<h1 id="publications-and-abstracts">Publications and abstracts</h1>

<ul>
  <li>
    <div itemscope="" itemtype="https://schema.org/Person"><a itemprop="sameAs" content="https://orcid.org/0000-0002-4543-7068" href="https://orcid.org/0000-0002-4543-7068" target="orcid.widget" rel="me noopener noreferrer" style="vertical-align:top;"><img src="https://orcid.org/sites/default/files/images/orcid_16x16.png" style="width:1em;margin-right:.5em;" alt="ORCID iD icon" />https://orcid.org/0000-0002-4543-7068</a></div>
  </li>
  <li><a href="https://scholar.google.com/citations?user=VlNJNQsAAAAJ&amp;hl=en">List of publications on Google scholar</a></li>
</ul>

<h4 id="publications">Publications</h4>

<ul>
  <li>
    <p>Clinical outcomes of escalation vs early intensive disease-modifying therapy in patients with multiple sclerosis
K Harding, O Williams, M Willis,  et al. JAMA neurology 76 (5), 536-541	57	2019</p>
  </li>
  <li>
    <p>Socioeconomic status and disability progression in multiple sclerosis: a multinational study
KE Harding, M Wardle, R Carruthers,  et al. Neurology 92 (13), e1497-e1506	18	2019</p>
  </li>
  <li>
    <p>A Case of Treatment Resistance and Complications in a Patient with Stiff Person Syndrome and Cerebellar Ataxia LA Jones, W Baber, M Wardle, et al. Tremor and Other Hyperkinetic Movements 9		2019</p>
  </li>
  <li>
    <p>Carroll LS, Massey TH, Wardle M, Peall KJ. Dentatorubral-pallidoluysian Atrophy: An Update. Tremor Other Hyperkinet Mov (N Y). 2018 Oct 1;8:577. doi: 10.7916/D81N9HST. PMID: 30410817; PMCID: PMC6222020.</p>
  </li>
  <li>
    <p>K Harding, V Anderson, O Williams, M Willis, S Butterworth, E Tallantyre. A contemporary study of mortality in the multiple sclerosis population of south east Wales. Multiple sclerosis and related disorders, 2018; 25, 186-191</p>
  </li>
  <li>
    <p>M Kopczynska, WM Zelek, S Vespa et al. Complement System Biomarkers in Epilepsy. Seizure-European Journal of Epilepsy		2018</p>
  </li>
  <li>
    <p>MO Alsaeed, KE Harding, OH Williams, MD Willis, J Hrastelj et al. Multiple sclerosis: Long‐term outcomes in ethnic minorities with MS: analysis of a UK population‐based registry. European Journal of Neurology	1	2018</p>
  </li>
  <li>
    <p>van de Zande NA, Massey TH, McLauchlan D, Pryce-Roberts A, Zutt R, Wardle M, Payne G, Clenaghan C, Tijssen MAJ, Rosser AE, Peall KJ. Clinical Characterisation of Dystonia in Patients with Huntington’s Disease. Eur J Neurol, 2017 [in press]</p>
  </li>
  <li>
    <p>Harding K, Tilling K, MacIver C, Willis M, Joseph F, Ingram G, Hirst C, Wardle M, Pickersgill TP, Robertson NP. Seasonal variation in multiple sclerosis relapse. J Neurol, 2017. doi:10.1007/s00415-017-8485-0</p>
  </li>
  <li>
    <p>Wardle M and Spencer A. <a href="http://m.futurehospital.rcpjournal.org/content/4/2/126">Implementation of SNOMED CT in an online clinical database</a>. Future Hosp J June 1, 2017 vol. 4 no. 2 126-130.</p>
  </li>
  <li>
    <p>Williams OH, Harding K, Rimmer A et al. Disease Modifying Treatments in MS: Clinical Outcomes of Induction and Escalation Strategies. MULTIPLE SCLEROSIS JOURNAL 2017:23 (2), 316-316.</p>
  </li>
  <li>
    <p>Harding KH, Williams OH, Willis MD et al. Socioeconomic Status and Disability in Multiple Sclerosis. MULTIPLE SCLEROSIS JOURNAL 23 (2), 322-322.</p>
  </li>
  <li>
    <p>Willis MD, Harding KE, Pickersgill TP, Wardle M, Pearson OR, Scolding NJ, Smee J, Robertson NP. <a href="https://www.ncbi.nlm.nih.gov/pubmed/26514979">Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort</a>. Mult Scler. 2016 Aug;22(9):1215-23. doi: 10.1177/1352458515614092.</p>
  </li>
  <li>
    <p>Wardle M, Sadler M <a href="http://pn.bmj.com/content/16/1/70">How to set up a clinical database</a> Practical Neurology 2016;16:70-74.</p>
  </li>
  <li>
    <p>Tallantyre EC, Wardle M, Robertson NP <a href="http://pn.bmj.com/content/16/1/62">How to run a multiple sclerosis relapse clinic</a> Practical Neurology 2016;16:62-69.</p>
  </li>
  <li>
    <p>Willis MD, Harding KE, Wardle M et al <a href="https://www.ncbi.nlm.nih.gov/pubmed/25196326">Site-specific clinical disease onset in multiple sclerosis.</a> Eur J Neurol. 2015 Apr;22(4):732-5. doi: 10.1111/ene.12564. Epub 2014 Sep 8.</p>
  </li>
  <li>
    <p>Peall KJ, Kurian MA, Wardle M et al. <a href="https://www.ncbi.nlm.nih.gov/pubmed/25209853">SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype.</a>
J Neurol. 2014 Dec;261(12):2296-304. doi: 10.1007/s00415-014-7488-3. Epub 2014 Sep 11.</p>
  </li>
  <li>
    <p>Harding KE, Wardle M, Moore P, Tomassini V, Pickersgill T, Ben-Shlomo Y, Robertson NP (2014). <a href="https://www.ncbi.nlm.nih.gov/pubmed/24828900">Modelling the natural history of primary progressive multiple sclerosis.</a> J Neurol Neurosurg Psychiatry. 2014 May 14. pii: jnnp-2014-307791.</p>
  </li>
  <li>
    <p>Peall KJ, Smith DJ, Kurian MA, Wardle M et al <a href="https://www.ncbi.nlm.nih.gov/pubmed/23365103">SGCE mutations cause psychiatric disorders: clinical and genetic characterization.</a> Brain. 2013 Jan;136(Pt 1):294-303.</p>
  </li>
  <li>
    <p>Moore P, Harding KE, Clarkson H, Pickersgill TP, Wardle M, Robertson NP (2013). <a href="http://journals.sagepub.com/doi/10.1177/1352458513481396">Demographic and clinical factors associated with changes in employment in multiple sclerosis.</a> Mult Scler. 2013 Oct;19(12):1647-54.</p>
  </li>
  <li>
    <p>Fawcett K, Mehrabian M, Liu YT, Hamed S, Elahi E, Revesz T, Koutsis G, Herscheson J, Schottlaender L, Wardle M, Morrison PJ, Morris HR, Giunti P, Wood N, Houlden H (2013) “The frequency of spinocerebellar ataxia type 23 in a UK population.” J Neurol. 2013 Mar;260(3):856-9. doi: 10.1007/s00415-012-6721-1. Epub 2012 Oct 30. Erratum in: J Neurol. 2013 Mar;260(3):860.</p>
  </li>
  <li>
    <p>Harding KE, Liang K, Cossburn MD, Ingram G, Hirst CL, Pickersgill TP, Te Water Naude J, Wardle M, Ben-Shlomo Y, Robertson NP (2013) “Long-term outcome of paediatric-onset multiple sclerosis: a population-based study.” J Neurol Neurosurg Psychiatry. 2013 Feb;84(2):141-7. doi: 10.1136/jnnp-2012-303996. Epub 2012 Nov 15.</p>
  </li>
  <li>
    <p>Becker EB, Zuliani L, Pettingill R, Lang B, Waters P, Dulneva A, Sobott F, Wardle M, Graus F, Bataller L, Robertson NP, Vincent A (2012) “Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.” J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):437-40. doi: 10.1136/jnnp-2011-301506. Epub 2012 Feb 15.</p>
  </li>
  <li>
    <p>Wardle, M.; Morris H.; Robertson, N. (2009), ‘Clinical and genetic characteristics of non-Asian dentatorubral pallidoluysian atrophy: A systematic review’. Mov Disord 24(11):1636-40.</p>
  </li>
  <li>
    <p>Wardle, M. (2009), ‘Cerebellar ataxia: A clinical and genetic study in South Wales’, MD thesis, Cardiff University.</p>
  </li>
  <li>
    <p>Wardle, M.; Majounie, E.; Muzaimi, M.; Williams, N.; Morris, H. &amp; Robertson, N. (2009), ‘The genetic aetiology of chronic progressive cerebellar ataxia: a population-based study’, J Neurol 256 (3):343-8. Epub 2009 Mar 6.</p>
  </li>
  <li>
    <p>Wardle, M.; Majounie, E.; Williams, N.; Rosser, A.; Morris, H. &amp; Robertson, N. (2008), ‘Dentatorubral pallidoluysian atrophy in South Wales’, J Neurol Neurosurg Psychiatry 79, 804-807.</p>
  </li>
  <li>
    <p>Majounie, E.; Wardle, M.; Muzaimi, M.; Cross, W.; Robertson, N. P.; Williams, N. &amp; Morris, H. (2007), ‘Case control analysis of repeat expansion size in ataxia.’, Neurosci Lett 429, 28-32.</p>
  </li>
  <li>
    <p>Wardle, M. &amp; Robertson, N. (2007), ‘Progressive late-onset cerebellar ataxia’, ACNR 7, 6-12.</p>
  </li>
</ul>

<h4 id="published-abstracts">Published abstracts</h4>

<ul>
  <li>
    <p>T Saad, K Dawson, C Hirst, I Baker, A Lowman, M Wardle, K Harding Epidemiology of motor neurone disease in wales
Journal of Neurology, Neurosurgery and Psychiatry 90 (12), e58</p>
  </li>
  <li>
    <p>K Harding, E Kingwell, M Wardle, F Zhu, N Robertson, H Tremlett Socioeconomic status and progression of disability in MS J Neurol Neurosurg Psychiatry 2018 89 (10), A21-A21</p>
  </li>
  <li>
    <p>M Alsaeed, K Harding, M Willis, E Tallantyre, M Wardle, T Pickersgill et al. Poster 1151: Ethnic minority outcomes in multiple sclerosis J Neurol Neurosurg Psychiatry 2017;88 (Suppl 1), A2-A2</p>
  </li>
  <li>
    <p>WO Pickrell, S Ahmed, SF Halpin, M Wardle, K Hamandi. Poster 0018 Two cases of subarachnoid haemorrhage caused by venous sinus thrombosis J Neurol Neurosurg Psychiatry 2017; 88 (Suppl 1), A17-A17</p>
  </li>
  <li>
    <p><a name="iPadParkinson">B. Mohamed, E.L. Lane, E.C. Thomas, M. Landwehr, C.W. Ngu, J. Butler, K. Williams, M. Wardle. <a href="http://www.mdsabstracts.org/abstract/ipad-based-preassessment-questionnaires-are-feasible-in-a-parkinsons-service/">iPad-based preassessment questionnaires are feasible in a Parkinson’s service [abstract]</a>. Mov Disord. 2016; 31 (suppl 2).</a></p>
  </li>
  <li>
    <p>Harding K, Williams O, Willis M, Wardle M, Pickersgill T, Robertson NP. <a href="http://jnnp.bmj.com/content/87/12/e1.229">CONTEMPORARY ANALYSIS OF MORTALITY IN MULTIPLE SCLEROSIS</a> J Neurol Neurosurg Psychiatry 2016;87:e1.</p>
  </li>
  <li>
    <p>Healy S, Nasser T, Willis M, et al <a href="http://jnnp.bmj.com/content/87/12/e1.72">THYROID AUTOIMMUNITY FOLLOWING ALEMTUZUMAB TREATMENT FOR MS</a> J Neurol Neurosurg Psychiatry 2016;87:e1.</p>
  </li>
  <li>
    <p>DISEASE MODIFYING TREATMENTS IN MS: INDUCTION OR ESCALATION? Owain H Williams, Katharine E Harding, Mark Willis, Trevor Pickersgill, Mark Wardle, Neil P Robertson J Neurol Neurosurg Psychiatry 2015;86:11 e4 doi:10.1136/jnnp-2015-312379.29</p>
  </li>
  <li>
    <p>DISEASE MODIFYING TREATMENT UTILISATION IN MULTIPLE SCLEROSIS Owain H Williams, Katharine E Harding, Mark Willis, Trevor Pickersgill, Mark Wardle, Neil P Robertson. J Neurol Neurosurg Psychiatry 2015;86:11 e4 doi:10.1136/jnnp-2015-312379.125</p>
  </li>
  <li>
    <p>Clinical characteristics and genetic testing of a Huntingtin mutation negative cohort [abstract]. Peall, K.J., Morris, H.R., Wardle, M.; Movement Disorders 2015;30 Suppl 1 :362</p>
  </li>
  <li>
    <p>FACTORS ASSOCIATED WITH EMERGENCY ATTENDANCES FOR EPILEPSY Lynch EC, Lacey AS, Pickrell WO, Smith PEM, Wardle M. J Neurol Neurosurg Psychiatry 2014;85:10. doi:10.1136/jnnp-2014-309236.73</p>
  </li>
  <li>
    <p>NO TEMPORAL EFFECT ON DISABILITY IN MULTIPLE SCLEROSIS Katharine Harding, Mark Willis, Mark Wardle, Trevor Pickersgill, Neil Robertson J Neurol Neurosurg Psychiatry 2014;85:10 e4 doi:10.1136/jnnp-2014-309236.10</p>
  </li>
  <li>
    <p><a href="http://jnnp.bmj.com/content/85/10/e4.194.short">ALEMTUZUMAB: LONG TERM FOLLOW-UP IN A SINGLE CENTRE COHORT</a> Mark Willis, Katharine Harding, Mark Wardle et al. J Neurol Neurosurg Psychiatry 2014;85:10 e4 doi:10.1136/jnnp-2014-309236.8</p>
  </li>
  <li>
    <p>LATE–ONSET MULTIPLE SCLEROSIS IN SOUTH–EAST WALES Katharine Harding, Megan Griffiths, Mark Wardle, Valentina Tomassini, Trevor Pickersgill, Neil Robertson J Neurol Neurosurg Psychiatry 2013;84:11 e2 doi:10.1136/jnnp-2013-306573.26</p>
  </li>
  <li>
    <p>EPISTATIC EFFECTS ON THE PHENOTYPE OF MULTIPLE SCLEROSIS Harding K, Loveless S, Wardle M et al J Neurol Neurosurg Psychiatry 2013;84:11 e2</p>
  </li>
  <li>
    <p>Neighbourhood socioeconomic status and multiple sclerosis: the impact of area level deprivation on multiple sclerosis risk frequency and disease progression Moore P, Harding K, Wardle M, Pickersgill TP, Robertson NP. Mult Scler, October 2013; vol. 19, 11 suppl: pp. 74-558.</p>
  </li>
  <li>
    <p>ARE PSYCHIATRIC SYMPTOMS A CORE PHENOTYPE OF MYOCLONUS DYSTONIA SYNDROME CAUSED BY SGCE MUTATIONS? KJ Peall, DJ Smith, MA Kurian, M Wardle et al J Neurol Neurosurg Psychiatry 2013;84:9 e1 doi:10.1136/jnnp-2013-306103.24</p>
  </li>
  <li>
    <p>IL-7, IL-9 and IL-12 are associated with current aspects of disease, but do not predict disease course in multiple sclerosis Harding, KE; Cossburn, MD; Moore, P; Pickersgill, TP; Wardle, M; Robertson, NP. MULTIPLE SCLEROSIS JOURNAL 18;117-117 Supplement: 4.OCT 2012</p>
  </li>
  <li>
    <p>Acute Stroke Thrombolysis-a Welsh centre’s perspective QTH Anjum, HGM Shetty, A Reed, TAT Hughes, PE Smith, T Pickersgill et al CEREBROVASCULAR DISEASES 35, 676-676</p>
  </li>
  <li>
    <p>DO AGE AT ONSET OR GENDER AFFECT ACCUMULATION OF DISABILITY IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS? K Harding, L Curzon, P Moore, MD Cossburn, G Ingram, TP Pickersgill, M Wardle, NP Robertson J Neurol Neurosurg Psychiatry 2012;83:Suppl 2 A35</p>
  </li>
  <li>
    <p>REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME AS A CAUSE OF SUBARACHNOID HAEMORRHAGE K Ali, Y Joshi, S Halpin, M Wardle J Neurol Neurosurg Psychiatry 2012;83:Suppl 2 A1 doi:10.1136/jnnp-2012-304200a.1</p>
  </li>
  <li>
    <p>‘Late onset cerebellar ataxia: natural history and prognosis’, Wardle, M.; Muzaimi, M.; Robertson, N. J Neurol Neurosurg Psychiatry 2008 80,97-128</p>
  </li>
  <li>
    <p>‘DRPLA in South Wales’, Wardle, M.; Majounie, E.; Williams, N.; Rosser, A.; Morris, H. &amp; Robertson, N. J Neurol Neurosurg Psychiatry 2007;78, 1014-1038.</p>
  </li>
</ul>

  </div>

</article>

      </div>
    </main><footer class="site-footer h-card">
  <data class="u-url" href="/"></data>

  <div class="wrapper">

    <h2 class="footer-heading">Health informatics and information technology</h2>

    <div class="footer-col-wrapper">
      <div class="footer-col footer-col-1">
        <ul class="contact-list">
          <li class="p-name">Health informatics and information technology</li><li><a class="u-email" href="mailto:mark@wardle.org">mark@wardle.org</a></li></ul>
      </div>

      <div class="footer-col footer-col-2"><ul class="social-media-list"><li><a href="https://github.com/wardle"><svg class="svg-icon"><use xlink:href="/assets/minima-social-icons.svg#github"></use></svg> <span class="username">wardle</span></a></li><li><a href="https://www.twitter.com/mwardle"><svg class="svg-icon"><use xlink:href="/assets/minima-social-icons.svg#twitter"></use></svg> <span class="username">mwardle</span></a></li></ul>
</div>

      <div class="footer-col footer-col-3">
        <p>by Dr Mark Wardle, Consultant Neurologist and Chief Clinical Information Officer (CCIO)
</p>
      </div>
    </div>

  </div>

</footer>
</body>

</html>
